Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
antibodies
Research
Trispecific antibody one-ups Tecvayli in myeloma mouse study
At one dosage, ISB 2001 completely eradicated the tumors of all eight mice; Tecvayli, meanwhile, had no complete regressions.
Darren Incorvaia
Sep 17, 2024 3:38pm
Diagonal launches with $128M to grow agonist antibody platform
Apr 3, 2024 6:00am
UW researchers deliver antibody-generating AI model
Mar 22, 2024 2:02pm
Genmab's growth plan entails partnering less, owning more: CEO
Mar 14, 2024 9:40am
Bicara raises second $100M+ round of 2023, closing new series C
Dec 12, 2023 6:30am
Regeneron snags $326M from BARDA for next-gen COVID antibody
Aug 23, 2023 7:15am